Geron | Eiendeler



Assets Endring Dato
Amgen USD 91.84B 956M 2024-12
Bio Techne USD 2.67B 65.59M 2024-12
Cassava Sciences USD 157.53M 66.22M 2024-12
Cytokinetics USD 1.4B 34.39M 2024-12
Exelixis USD 2.95B 12.59M 2025-01
Genmab DKK 45.81B 6.15B 2024-12
Geron USD 593.78M 148.83M 2024-12
Gilead Sciences USD 59B 4.47B 2024-12
Incyte USD 5.44B 431.89M 2024-12
MacroGenics USD 261.65M 2.84M 2024-12
Novartis USD 102.25B 1.28B 2024-12



Geron Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.